Improving quality of life for breast cancer patients during chemotherapy
Quality of Life Improvement of Breast Cancer Patients During Chemotherapy With Structured Psychological Interventions
This study is testing if adding hypnotherapy to standard care can help women with breast cancer feel better during chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 62 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Basel, Canton of Basel-City) |
| Trial ID | NCT04694885 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial at the University Hospital Basel aims to enhance the quality of life for female breast cancer patients undergoing chemotherapy through structured hypnotherapy. Participants in the intervention group will receive 10 sessions of hypnotherapy alongside standard care, while the control group will only receive standard care. The study will assess the impact of hypnotherapy on quality of life, chemotherapy side effects, anxiety and depression symptoms, immune system function, and treatment adherence. The findings could lead to updates in psycho-oncological care if positive outcomes are observed.
Who should consider this trial
Good fit: Ideal candidates are female patients aged 18 and older who are receiving neo-adjuvant or adjuvant chemotherapy for primary breast cancer.
Not a fit: Patients with verbal or cognitive deficits, psychological disorders, or acute suicidality may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and overall well-being of breast cancer patients during chemotherapy.
How similar studies have performed: Emerging evidence suggests that hypnotherapy has been effective in reducing treatment side effects and improving mental health in cancer patients, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Minimum Age 18 years * Female * Primary breast cancer * Receiving neo-adjuvant or adjuvant chemotherapy Exclusion Criteria: * Verbal or cognitive deficits that are not compatible with outpatient psychotherapy * Not consenting patients and vulnerable persons * Psychological disorders that prevent patients from participating in the study (e.g. psychotic disorder) * acute suicidality
Where this trial is running
Basel, Canton of Basel-City
- University Hospital Basel — Basel, Canton of Basel-City, Switzerland (Recruiting)
Study contacts
- Principal investigator: Christian Schwegler, Dr. — University Hospital, Basel, Switzerland
- Study coordinator: Christian Schwegler, Dr.
- Email: christian@praxisschwegler.ch
- Phone: +49 (0)170 472 47 47
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.